HM Payson & Co. bought a new stake in Maximus, Inc. (NYSE:MMS) in the 4th quarter, HoldingsChannel reports. The institutional investor bought 6,125 shares of the health services provider’s stock, valued at approximately $448,000.
Several other hedge funds have also added to or reduced their stakes in the company. Amundi Pioneer Asset Management Inc. grew its holdings in shares of Maximus by 16.5% in the fourth quarter. Amundi Pioneer Asset Management Inc. now owns 262,860 shares of the health services provider’s stock valued at $19,243,000 after acquiring an additional 37,188 shares in the last quarter. Dimensional Fund Advisors LP grew its holdings in shares of Maximus by 3.5% in the fourth quarter. Dimensional Fund Advisors LP now owns 789,930 shares of the health services provider’s stock valued at $57,814,000 after acquiring an additional 26,656 shares in the last quarter. Norges Bank bought a new position in shares of Maximus in the fourth quarter valued at approximately $52,330,000. UBS Asset Management Americas Inc. grew its holdings in shares of Maximus by 6.5% in the fourth quarter. UBS Asset Management Americas Inc. now owns 203,308 shares of the health services provider’s stock valued at $14,880,000 after acquiring an additional 12,421 shares in the last quarter. Finally, Principal Financial Group Inc. grew its holdings in shares of Maximus by 2.9% in the fourth quarter. Principal Financial Group Inc. now owns 194,763 shares of the health services provider’s stock valued at $14,254,000 after acquiring an additional 5,430 shares in the last quarter. 92.89% of the stock is owned by institutional investors.
Separately, Raymond James upped their target price on Maximus from $90.00 to $96.00 and gave the company a “strong-buy” rating in a report on Friday, February 5th.
In other Maximus news, Vice Chairman Richard A. Montoni sold 12,000 shares of the stock in a transaction on Tuesday, March 23rd. The stock was sold at an average price of $87.13, for a total transaction of $1,045,560.00. The transaction was disclosed in a filing with the SEC, which is accessible through this link. Also, Vice Chairman Richard A. Montoni sold 11,000 shares of the stock in a transaction on Thursday, March 25th. The stock was sold at an average price of $86.45, for a total value of $950,950.00. The disclosure for this sale can be found here. 2.00% of the stock is currently owned by corporate insiders.
Shares of NYSE MMS opened at $91.18 on Thursday. The stock has a fifty day simple moving average of $85.94 and a two-hundred day simple moving average of $76.19. Maximus, Inc. has a 1-year low of $59.17 and a 1-year high of $94.19. The firm has a market cap of $5.60 billion, a price-to-earnings ratio of 26.82 and a beta of 0.84. The company has a current ratio of 1.66, a quick ratio of 1.66 and a debt-to-equity ratio of 0.01.
Maximus (NYSE:MMS) last announced its quarterly earnings data on Thursday, February 4th. The health services provider reported $1.03 earnings per share for the quarter, beating the consensus estimate of $0.94 by $0.09. Maximus had a return on equity of 17.60% and a net margin of 6.20%. The business had revenue of $945.60 million during the quarter, compared to analyst estimates of $846.46 million. During the same period in the prior year, the company earned $0.91 earnings per share. Maximus’s revenue was up 15.6% compared to the same quarter last year. Analysts forecast that Maximus, Inc. will post 3.63 EPS for the current year.
The company also recently disclosed a quarterly dividend, which was paid on Friday, February 26th. Shareholders of record on Friday, February 12th were issued a dividend of $0.28 per share. This represents a $1.12 annualized dividend and a yield of 1.23%. The ex-dividend date was Thursday, February 11th. Maximus’s dividend payout ratio (DPR) is 33.04%.
Maximus, Inc provides business process services (BPS) to government health and human services programs worldwide. It operates through three segments: U.S. Services, U.S. Federal Services, and Outside the U.S. The U.S. Services segment offers various BPS solutions, such as program administration, appeals and assessments, and related consulting works for U.S.
Further Reading: Penny Stocks
Want to see what other hedge funds are holding MMS? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Maximus, Inc. (NYSE:MMS).
Receive News & Ratings for Maximus Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Maximus and related companies with MarketBeat.com's FREE daily email newsletter.